Both the mean SiDBP and SiSBP at baseline were similar between the treatment groups, 171.0/113.4 mm Hg for the losartan/HCTZ combination arm and 170.5/113.3 mm Hg for the losartan monotherapy arm.
The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an ...
The baseline demographics showed patients treated with placebo, telmisartan 40 or 80 mg, or comparators (losartan 50 mg, valsartan 80 mg, or amlodipine 5 mg) to be similar with respect to age ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results